Hikma Pharmaceuticals Overview
- Founded
- 1978

- Status
- Public
- Employees
- 8,600

- Stock Symbol
- HIK

- Investments
- 19
- Share Price
- $34.75
- (As of Friday Closing)
Hikma Pharmaceuticals General Information
Description
Founded in the Middle East and with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, branded, and other, which comprise most of the company's revenue at about 41%, 33%, and 26%, respectively. About 62%, 33%, and 6% of Hikma's sales are based in the U.S., Middle East, North Africa, and Europe, and Other.
Contact Information
- 1 New Burlington Place
- London W1S 2HR
- England, United Kingdom
Hikma Pharmaceuticals Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$34.75 | $35.39 | $18.75 - $36.80 | $8.16B | 230M | 568K | $2.12 |
Hikma Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 6,529,219 | 6,688,814 | 5,750,556 | 4,294,666 |
Revenue | 2,292,000 | 2,207,000 | 2,070,000 | 1,936,000 |
EBITDA | 742,000 | 676,000 | 470,000 | (553,000) |
Net Income | 513,000 | 486,000 | 282,000 | (843,000) |
Total Assets | 3,970,000 | 3,930,000 | 3,497,000 | 3,388,000 |
Total Debt | 927,000 | 685,000 | 637,000 | 777,000 |
Hikma Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Hikma Pharmaceuticals‘s full profile, request access.
Request a free trialHikma Pharmaceuticals Comparisons
Industry
000000 0
000 0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialHikma Pharmaceuticals Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Takeda Pharmaceutical Company | Corporation | Tokyo, Japan | 00000 | 00000000 | ||
000 00000000000000 | Corporation | Mumbai, India | 00000 | 00000000000 | ||
000000 | Corporation | Maharashtra, India | 0000 |
Hikma Pharmaceuticals Executive Team (26)
Hikma Pharmaceuticals Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
000000 0000 | Self | Board Member | 000 0000 |
0000 0000000000 | Hikma Pharmaceuticals | Board Member | 000 0000 |
00000 00000000 | Hikma Pharmaceuticals | Director & Vice Chairman | 000 0000 |
00000000 000 00-00000 | Self | Board Member | 000 0000 |
0000 000000000 | Self | Board Member | 000 0000 |
Hikma Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHikma Pharmaceuticals Investments & Acquisitions (19)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 (000 | 02-Jan-2019 | 000000000000000000 | 0000.00 | Medical Supplies | 0000 000000000 |
000000 00000000000 | 29-Feb-2016 | 000000000000000000 | 00.000 | Pharmaceuticals | 0000 00000000 |
0000 000000 000000 | 08-Sep-2015 | 000000000000000000 | 0000 | Drug Discovery | |
000000000000000 00 | 17-Sep-2014 | 000000000 00000 00 | Buildings and Property | 0000 00000000 | |
Bedford Laboratories | 15-Jul-2014 | Merger/Acquisition | 00000 | Medical Supplies | 0000 00000000 |
Hikma Pharmaceuticals Subsidiaries (4)
Company Name | Industry | Location | Founded |
---|---|---|---|
Hikma Ventures | Corporate Venture Capital | London, United Kingdom | 2015 |
00000000000 | Distributors (Healthcare) | Gräfelfing, Germany | 0000 |
0000 0000000000000 | Acquirer | Al Salt, Jordan | 0000 |
0000000000 | Pharmaceuticals | Casablanca, Morocco | 0000 |
Hikma Pharmaceuticals Exits (3)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000000000000 00 | 17-Sep-2014 | 000000000 00000 00 | Completed |
|
|
000 00000 00000000 | 15-Jul-2014 | 000000000000000000 | 00000 | Completed |
|
Unimark Remedies | 15-Apr-2011 | Corporate | 000.00 | Completed |